NeoGenomics, Inc. Reports Third Quarter 2026 Total Revenue of $209 million

NeoGenomics, Inc. reported its financial results for the third quarter ended September 30, 2026, with total revenue incr...

By Dhallo News · October 29, 2026 at 6:01 AM IST

NeoGenomics, Inc. reported its financial results for the third quarter ended September 30, 2026, with total revenue increasing 11% year-over-year to $209 million. Clinical revenue grew 13% to $195 million, driven by NGS growth of 29%. The company's GAAP gross margin expanded by 3

SOURCE: Nasdaq

ORIGINAL REPORT: Click here

DHALLO EDITORIAL STATUS: Aggregated & reviewed

Have feedback on this article?Report error or suggestion

NeoGenomics, Inc. Reports Third Quarter 2026 Total Revenue of $209 million

Read More from Markets

Cotton Closes Higher on Wednesday

Climb Global Solutions Reports Record Third Quarter 2026 Results with Net Sales Up 37% to $220.3 million

Taiwan Stock Market May See Continued Strength On Thursday

5 minutes. The news that matters.